Big Pharma to Testify in High Drug Pricing Case
12 February 2019
While congressional scrutiny on drug pricing is nothing new, the prospect of some of the pharmaceutical industry’s highest-profile CEOs testifying on the issue will make for a must-watch event.
Pilot Project for Drug Supply Chain Security Act of FDA
12 February 2019
A key element of the U.S. Food and Drug Administration’s mission is focused on helping to ensure that all products FDA regulates, including drugs available to consumers, are safe and of high quality. This means working to ensure greater accountability in nation’s drug supply chain.
Thai Company to Build Factory in Russia
11 February 2019
The pharmaceutical company Besins Healthcare SA will build an integrated factory in Yaroslavl (250 miles north of Moscow) for producing Utrogestan, a drug to prevent premature births and miscarriages. The company’s representative office in Russia signed an agreement with the Yaroslavl Region government at the end of November. The news was announced by deputy chairman of the regional government Maxim Avdeyev at an itinerant session of the St. Petersburg International Economic Forum “Russian regions: New points of growth,” held in early December.
Russian Scientists Developed Cancer Drug
11 February 2019
Russian scientists have developed a new drug for the treatment of cancer, which is comparable to the drug whose creators were awarded the Nobel Prize last year, and its certification is expected to take place in 2019, a Russian researcher told.
Matching Personal and Company Success
08 February 2019
The biopharma industry has found itself under political and societal microscopes in recent years, as executives search for answers to criticisms about high drug prices, shortages of vital therapies, and the industry’s role in the opioid epidemic. Meanwhile, a record number of new drug approvals and the emergence of innovative therapies demonstrate the potential of bio/pharma R&D efforts.
Pharma CEOs enthuse about Trump's plan to shake up drug rebates
08 February 2019
Sweep out drug rebates for patient discounts instead? Big Pharma CEOs are all over it. A week after the Trump administration proposed ending drug rebates in federal health programs—and then urged Congress to extend that plan to commercial insurance—supply chain players are hitting back. The pharmacy benefit manager (PBM) industry has even launched an ad campaign.
New Law, Control Russian Med Products
07 February 2019
The President of the Russian Federation has signed Federal Law no. 511-FZ “On amendments to certain legislative acts of the Russian Federation”/ According to the new law, the regulator (Roszdravnadzor) has been granted a new function to carry out controlled purchases from retailers at any time without warning the retailer.
Importance of Introducing Forced Licensing in Russia
07 February 2019
Many international experts and scholars underline that excessive imbalanced protection of intellectual property can prevent development of innovations and scientific-and-technological progress. In this context, measures towards protecting intellectual property must be balanced by relevant opportunities, - stated Head of FAS Department for Control over Social Sphere and Trade, Timophei Nizhegorodtsev at the X Gaidar Forum.
IQVIA Launches Services for Emerging Biopharma Needs
06 February 2019
IQVIA has launched IQVIA Biotech and its new approach to providing clinical and commercial services for small biotech and biopharma companies. The solutions suite will provide simplified operating procedures, specialized teams, and services to help biopharma clients reach their drug development and commercialization milestones. IQVIA Biotech aims to deliver a transparent and streamlined process from initial planning to trial design and implementation to market launch and commercialization.
Russia to Inspect British Pharma Manufacturers
06 February 2019
The Russian Ministry of Industry and Trade’s State Institute of Drugs and Good Practices plans to inspect five British pharmaceutical manufacturers for compliance with GMP standards in 2019. That’s according to the institute’s director, Vladislav Shestakov.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024